Novel transcript, antisense to GNGT1 and GNG11 (ENSG00000306701)

This molecule is best described as a "novel long non-coding RNA (lncRNA) transcript, antisense to GNGT1 and GNG11," with no established common alias, protein translation, or demonstrated functional role. It does not encode a known protein and is not recognized as a therapeutic target or as having an annotated disease function. The gene is located near the protein-coding gene GNG11; its function and relevance remain unclear in the current databases, and it is not considered a canonical drug target[1][6][7]. Key points: - This entry is a non-coding transcript with antisense orientation to GNGT1 and GNG11, most likely identified through genome annotation efforts, and has not been characterized as a protein, receptor, enzyme, or other classical therapeutic target class[1][7]. - The designation “novel transcript” means the precise biological role is unknown, making it unsuitable as a current therapeutic target and highlighting a need for caution in further interpretation. - There is no evidence of interacting drugs, disease associations, mechanisms of drug action, biomarker roles, or safety concerns directly associated with this transcript. - The is_incorrect field is set to true as this is not a recognized target in the sense of receptors, enzymes, or similar actionable biomolecules—there is insufficient evidence or established function for structured target-based drug discovery or clinical investigation[7].